MKC Q3 Earnings Beat Estimates on Margin Gains and Mexico Growth

McCormick posted fiscal Q3 2026 adjusted EPS of $0.86, up 1.2% year over year and $0.11 above the $0.75 consensus, while sales rose 17.4% to $2.025B versus $1.979B expected. Organic sales increased 1.9% and adjusted gross margin expanded 180bps to 39.3%, with the McCormick de Mexico acquisition contributing 14.6 percentage points to reported sales growth. The company reaffirmed FY2026 EPS guidance of $3.05-$3.13 and sales-growth guidance of 13%-17%, but expects organic growth toward the low-to-midpoint of its 1%-3% range amid 6%-7% cost inflation, higher Q4 commodity and freight expenses, and packaging constraints.

Analysis

The earnings beat is lower quality than the headline implies: pricing remains the principal organic growth engine while Consumer volumes are negative, and the outlook effectively anchors organic growth near 1%. That mix limits the durability of a post-results rerating because productivity and acquired-margin accretion can support FY26 earnings, but cannot indefinitely offset weak unit elasticity. The relevant 1-3 month debate is whether sell-side estimates still embed a cleaner exit rate than management’s revised organic-growth framing.

Fourth-quarter margin is the key near-term catalyst, not revenue. Higher input and freight costs, incremental Consumer investment, and a packaging constraint create a setup where a small miss in gross-margin delivery could drive disproportionate EPS revisions, especially given the stock’s defensive valuation profile. The balance sheet also matters ahead of the Unilever Foods transaction: deleveraging progress is necessary to preserve strategic flexibility, and a higher-rate or weaker-cash-conversion outcome would make the acquisition-led growth model less attractive.

Flavor Solutions’ positive volume/mix and Asia-Pacific momentum suggest the better competitive read-through is to foodservice-exposed packaged-food suppliers rather than broad staples. MDLZ has a cleaner standalone organic-growth and balance-sheet narrative, but cocoa remains a distinct cost risk; it is not a direct substitute for MKC. Contrarianly, the sharp prior drawdown may have already discounted weak Consumer volume, so a tactical bounce is plausible if fourth-quarter margin holds—but that is not yet evidence of a structural turn in underlying demand.

Key Decisions for Investors

• Maintain MKC as neutral-to-underweight into the next print; do not chase an earnings-day rally. Reassess for a tactical long only if fourth-quarter gross margin holds guidance despite inflation and Consumer volume turns non-negative. Thesis is falsified by an EPS-guide cut or net leverage failing to decline from roughly 2.9x.
• Express relative quality via long MDLZ / short MKC over 3-6 months, sized beta-neutral. MDLZ offers a more straightforward growth setup, while MKC faces a lower organic exit rate and transaction/deleveraging execution risk; exit if MKC delivers two consecutive quarters of positive Consumer volume plus sustained margin expansion.
• Monitor packaging-material availability and spot freight/commodity trends as a pre-earnings alert. A resolution before quarter end, combined with continued productivity savings, would remove the primary near-term short catalyst and argues against adding to MKC downside.
• Avoid using MAMA or LSF as read-through trades: their small-cap, idiosyncratic growth and liquidity profiles make their earnings momentum non-comparable to MKC’s mature branded-staples demand signal.